Irreversible alterations such as B2M mutations and HLA class I loss of heterozygosity (LOH) are frequently observed in melanoma, lung cancer, and microsatellite instability–high colorectal cancer, particularly in tumours that relapse after immune checkpoint blockade.81, 82. The gene discussed is B2M; the disease is melanoma.